Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Navigating Latinas with breast screen abnormalities to diagnosis: the Six Cities Study.

Ramirez AG, Pérez-Stable EJ, Penedo FJ, Talavera GA, Carrillo JE, Fernandez ME, Holden AE, Munoz E, San Miguel S, Gallion K.

Cancer. 2013 Apr 1;119(7):1298-305. doi: 10.1002/cncr.27912. Epub 2012 Dec 10.

2.

Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.

Markossian TW, Darnell JS, Calhoun EA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1691-700. doi: 10.1158/1055-9965.EPI-12-0535.

3.

Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women.

Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ.

J Womens Health (Larchmt). 2015 Feb;24(2):138-43. doi: 10.1089/jwh.2014.4954. Epub 2014 Dec 18.

4.

Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities.

Dudley DJ, Drake J, Quinlan J, Holden A, Saegert P, Karnad A, Ramirez A.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1639-44. doi: 10.1158/1055-9965.EPI-12-0538.

5.

Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study.

Ramirez AG, Pérez-Stable EJ, Talavera GA, Penedo FJ, Carrillo JE, Fernandez ME, Muñoz E, Long Parma D, Holden AE, San Miguel de Majors S, Nápoles A, Castañeda SF, Gallion KJ.

Springerplus. 2013 Dec;2(1):84. doi: 10.1186/2193-1801-2-84. Epub 2013 Mar 5.

6.

Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study.

Ramirez A, Perez-Stable E, Penedo F, Talavera G, Carrillo JE, Fernández M, Holden A, Munoz E, San Miguel S, Gallion K.

Cancer. 2014 Mar 1;120(5):752-60. doi: 10.1002/cncr.28450. Epub 2013 Nov 12.

7.

Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.

Palmieri FM, DePeri ER, Mincey BA, Smith JA, Wen LK, Chewar DM, Abaya R, Colon-Otero G, Perez EA.

Mayo Clin Proc. 2009 Apr;84(4):317-22. doi: 10.1016/S0025-6196(11)60539-9.

8.
9.

Linked claims and medical records for cancer case management : evaluation of mammography abnormalities.

Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Broffman G, Fox CH, Mahoney MC, Edge SB.

Cancer. 2007 Aug 1;110(3):518-24.

10.

The impact of a culturally tailored patient navigator program on cervical cancer prevention in Latina women.

Percac-Lima S, Benner CS, Lui R, Aldrich LS, Oo SA, Regan N, Chabner BA.

J Womens Health (Larchmt). 2013 May;22(5):426-31. doi: 10.1089/jwh.2012.3900. Epub 2013 Apr 26.

11.

Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.

Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R; National Institutes of Health Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2007 Mar 7;99(5):386-95.

12.

Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.

Ciatto S, Houssami N, Ambrogetti D, Bonardi R, Collini G, Del Turco MR.

Breast Cancer Res Treat. 2007 Sep;105(1):37-43. Epub 2006 Nov 18.

PMID:
17115112
13.
14.

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.

Timmers JM, van Doorne-Nagtegaal HJ, Zonderland HM, van Tinteren H, Visser O, Verbeek AL, den Heeten GJ, Broeders MJ.

Eur Radiol. 2012 Aug;22(8):1717-23. doi: 10.1007/s00330-012-2409-2. Epub 2012 Mar 14.

15.

Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.

Battaglia TA, Bak SM, Heeren T, Chen CA, Kalish R, Tringale S, Taylor JO, Lottero B, Egan AP, Thakrar N, Freund KM.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1645-54. doi: 10.1158/1055-9965.EPI-12-0532.

16.

Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.

Hoffman HJ, LaVerda NL, Young HA, Levine PH, Alexander LM, Brem R, Caicedo L, Eng-Wong J, Frederick W, Funderburk W, Huerta E, Swain S, Patierno SR.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1655-63. doi: 10.1158/1055-9965.EPI-12-0479.

17.

Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.

Chung CS, Giess CS, Gombos EC, Frost EP, Yeh ED, Raza S, Birdwell RL.

AJR Am J Roentgenol. 2014 Apr;202(4):922-7. doi: 10.2214/AJR.13.11137.

PMID:
24660725
18.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K.

Breast Cancer Res. 2015 Jan 8;17:1. doi: 10.1186/s13058-014-0509-4.

19.

Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.

Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D; Denver Patient Navigation Research Program.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1629-38. doi: 10.1158/1055-9965.EPI-12-0513.

20.

Mammography in asymptomatic women aged 40-49 years.

Silva FX, Katz L, Souza AS, Amorim MM.

Rev Saude Publica. 2014 Dec;48(6):931-9. doi: 10.1590/S0034-8910.2014048005349. English, Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk